Takeda Pharmaceutical Co Ltd ADR

Stock Chart, Company Information, and Scan Results

$15.16(as of Sep 2, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Takeda Pharmaceutical Co Ltd ADR Company Information, Fundamentals, and Technical Indicators

Stock Price$15.16
Ticker SymbolTAK
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees47,455
CountyUSA
Market Cap$47,551.0M
EBIDTA1,219,015.0M
10-Day Moving Average15.14
P/E Ratio0.35
20-Day Moving Average14.88
Forward P/E Ratio14.73
50-Day Moving Average14.79
Earnings per Share0.29
200-Day Moving Average14.17
Profit Margin11.23%
RSI57.15
Shares Outstanding3,158.2M
ATR0.22
52-Week High15.56
Volume2,393,566
52-Week Low12.51
Most Recent Support Level14.90
Book Value6,866,180.0M
Most Recent Resistance Level15.53
P/B Ratio0.01
Upper Keltner15.37
P/S Ratio0.01
Lower Keltner14.38
Debt-to-Equity Ratio15.37
Next Earnings Date10/30/2025
Cash Surplus-1,819,578.0M
Next Ex-Dividend DateUnknown

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.

Takeda Pharmaceutical Co Ltd ADR In Our Stock Scanner

As of Sep 03, 2025
As of ---
example chart graphic
Scan Name: Low PE RatiosScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---
As of ---
As of ---
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.